For instance, it is established that proteolysis of interferon-β (IFN-β) by MMP-9 is hindered by glycosylation (43) and that, maybe thereby, less neutralizing antibodies are formed in multiple sclerosis (MS) patients treated with glycosylated IFN-β (44). The gene discussed is MMP9; the disease is myeloid sarcoma.